Gene testing helps guide prostate treatment

Testing prostate cancer patients for inherited mutations in key DNA repair genes could identify men who may benefit from new precision treatments, a new study has revealed

12%

of advanced prostate cancer patients tested had at least one 'germline' mutation in a DNA repair gene

5%

of men tested had a mutation in their BRCA2 gene